Why grade IV post-traumatic damage needs more than cartilage repair

When a knee sustains a serious impact — a high-energy fall, a road collision, or an intra-articular fracture — the damage commonly runs deeper than the cartilage surface. ICRS Grade IV lesions, the most severe classification, penetrate all the way through the cartilage and into the subchondral bone beneath. This is a structural injury, not simply a surface one.

That distinction is what drives the treatment decision. Standard cartilage repair techniques — microfracture, ACI, and MACI — work by regenerating or replacing the cartilage layer. Microfracture creates a fibrocartilage clot from marrow; ACI and MACI cultivate cartilage cells on a scaffold. All three depend on an intact, stable subchondral bone bed as a foundation for the repair. Where trauma has damaged, cystic, or eroded that bone, there is nothing solid left for those techniques to build upon.

Post-traumatic lesions are also typically large — commonly exceeding 2–4 cm² — which places them outside the reliable range for marrow-stimulation and stretches the limits of cell-based grafting even further.

Fresh osteochondral allograft (OCA) transplantation is designed for exactly this combination. In a single operation it transfers a size-matched plug of mature donor hyaline cartilage together with its supporting bone, addressing both layers simultaneously. It occupies a specific position in the joint-preservation hierarchy — above biologic and cell-based repair, below joint replacement — for patients whose anatomy and age make preservation the priority.

Who is a suitable candidate for OCA

The clearest candidate for OCA is a younger, active patient — typically under 50 — with a single, symptomatic, full-thickness lesion on the femoral condyle, whose defect is large enough (commonly more than 2–4 cm²) to have exceeded what microfracture, OATS autograft, or cell-based techniques can reliably address. That size threshold matters because OATS is constrained by donor-site availability to roughly 2.5 cm², and MACI, while effective for larger chondral-only defects, cannot independently restore subchondral bone.

The most decisive factor, however, is not size alone but bone status. When the subchondral layer is damaged, cystic, or substantially lost — as is common after intra-articular fracture or high-energy impact — OCA is the appropriate single-stage solution, because it replaces both tissue layers simultaneously. A patient who fits the size criterion but has an intact subchondral bed may have a reasonable alternative in ACI or MACI; a patient with bone loss does not.

Several factors disqualify or substantially complicate candidacy. Inflammatory arthritis and diffuse osteoarthritis are contraindications, because widespread joint disease makes focal graft restoration unrealistic. Uncorrectable lower-limb malalignment is similarly a barrier — though correctable malalignment is a distinct situation that can be addressed alongside OCA, as discussed in the section on alignment below. Significant meniscal deficiency must also be considered; where this can be addressed simultaneously, candidacy may still be appropriate, but unresolved meniscal loss increases loading on any graft.

Bipolar lesions — where cartilage is damaged on both sides of the joint — and revision scenarios carry meaningfully lower graft survivorship and warrant careful individual counselling. Patellar lesions sit in their own sub-category: OCA can be performed on the patella, but survivorship data from patellofemoral series (82.6% at 5 years, 69.6% at 10 years) fall below the figures reported for condylar OCA, and outcomes should be discussed accordingly before surgery.

Choosing OCA over ACI, MACI, or microfracture

The decision logic follows a three-step sequence, each question narrowing the field.

Bone status comes first

When the subchondral layer is intact, ACI and MACI are legitimate alternatives: a 148-patient cohort study (mean follow-up 6.7 years) found no significant difference in KOOS JR or IKDC scores between ACI and OCA for defects without bone involvement, though no randomised trial has specifically tested this comparison within a post-traumatic population. The pivotal shift comes when bone is damaged, cystic, or substantially lost — at that point neither ACI nor MACI can independently rebuild the subchondral bed, and OCA is the appropriate single-stage solution.

Defect size is the secondary filter

For lesions approaching or exceeding 4 cm², cell-based repair becomes progressively less reliable as a cartilage-only technique, and OCA's size-matched structural plug offers coverage that ACI and MACI cannot match at that scale. Microfracture occupies an even narrower position: suited to small (<2 cm²), contained lesions with an intact bone plate, it is not an appropriate choice for grade IV post-traumatic damage. Microfracture produces fibrocartilage rather than hyaline cartilage, and clinical scores for larger lesions decline at medium-term follow-up. The SUMMIT trial demonstrated MACI's superiority over microfracture for defects of 3 cm² or more — but even MACI is confined to the cartilage layer and cannot address concurrent subchondral loss.

Staging preference plays a supporting role

ACI and MACI require two separate procedures — initial chondrocyte biopsy, laboratory cell culture, then re-implantation — spaced several weeks apart. For post-traumatic patients who have often already undergone emergency surgery or multiple earlier interventions, OCA's single-operation character is a practical advantage that many patients weigh meaningfully in their decision.

Long-term outcomes and what the evidence shows

Survivorship data from the largest long-term cohort — 60 patients, mean age 28.9 years, followed to 25 years — show graft retention of 87.3% at 5 years and 85.0% at 10 years when OCA was combined with concurrent realignment osteotomy. At the population level, meta-analytic figures place 10-year survivorship at approximately 78.7%, with around 90% of patients retaining their graft to at least that point. Both figures hold up well against the alternative of early joint replacement in young patients.

At 25 years in the same long-term series, survivorship falls to 59.8%. That decline is worth stating plainly: OCA is not a permanent solution in the way that a cemented joint replacement aims to be. For a patient in their late twenties or thirties, however, a procedure that preserves their own joint for two decades before any further intervention carries considerable clinical value — and a subsequent revision OCA or knee replacement, if eventually required, remains on the table.

Functional results reflect the structural picture. At mean six-year follow-up, 75.2% of 149 knees had returned to sport or recreational activity, approximately 71% of patients reported 'very good' to 'excellent' knee function, and mean modified Hospital for Special Surgery scores improved significantly after surgery.

A figure that merits specific explanation for patients is the approximately 40% reoperation rate. Most of these reoperations are minor secondary arthroscopic procedures — hardware removal, adhesion release, or debridement — rather than graft failures. True failure, defined as revision OCA or conversion to total knee replacement, is a distinct and less common endpoint. Conflating the two numbers would substantially overstate the clinical risk; surgeons discussing OCA routinely separate them during consent.

Evidence on optimal donor graft storage time and the precise immunological response to OCA remains an active area of research, which means some comparative certainty limits are inherent to the current literature.

The role of alignment, meniscus, and ligament stability

Getting the graft in is only part of the operation. What determines whether it survives long-term is the mechanical environment it is placed into — shaped by three factors that exist independently of the cartilage defect itself: limb alignment, meniscal integrity, and ligamentous stability.

Malalignment carries the greatest statistical weight

Persistent postoperative malalignment is the strongest predictable risk factor in the outcome data. In the Bone & Joint long-term cohort, patients with uncorrected malalignment had a hazard ratio of 6.55 for graft failure (95% CI 1.61–27.71; p=0.009). In plain terms, transplanting a healthy graft into a malaligned knee leaves it bearing disproportionate load on the very surface that has just been restored. Where a mechanical axis problem is present — typically varus for medial compartment lesions (addressed with a high tibial osteotomy) or valgus for lateral involvement (distal femoral osteotomy) — alignment correction must be performed concurrently or staged appropriately, not deferred.

Meniscus and ligament status

Meniscal deficiency and untreated ligamentous instability place excess load on the graft and must be addressed before or during OCA. Post-traumatic knees carry a higher likelihood of concurrent ACL, PCL, or meniscal injury from the original event; thorough pre-operative assessment — including MRI evaluation — is essential before proceeding.

The patellofemoral caveat

Patients with traumatic patellar cartilage damage occupy a distinct category. Published evidence indicates that traumatic patellofemoral pathology produces lower patient-reported outcomes and higher failure rates than degenerative patellofemoral lesions, even after technically successful OCA. This differs meaningfully from the condylar evidence base and warrants specific discussion at consultation rather than assuming parity with femoral condyle results.

Assessment and next steps for Lincolnshire patients

Confirming OCA candidacy depends on detailed pre-operative imaging. MRI remains the essential starting point: it characterises lesion size, depth, cartilage thickness, and — critically — the extent of subchondral bone involvement that determines whether a cell-based technique remains viable or OCA is the appropriate choice. Where the MRI includes cartilage segmentation and T2 mapping, clinicians gain a more objective picture of tissue quality beyond what visual read alone provides; Lincolnshire Knee uses onMRI™ AI-driven analysis to support this step.

Where lower-limb malalignment is a clinical concern — as the hazard-ratio data make clear, it needs to be identified and addressed — gait and biomechanical assessment can provide objective information to guide that decision. MAI Motion® objective movement analysis is available as part of the assessment pathway for patients in whom alignment is a factor.

For UK patients, the October 2022 NHS England routine commissioning decision removed the prior individual funding request requirement for OCA; patients who have an NHS pathway may find this changes their access options.

Lincolnshire Knee is part of the MSK Doctors group and accepts patients without referral. Book an assessment at lincolnshireknee.co.uk.